Consideration received from the sale is Rs 180 crore, the filing said.Shares of GlaxoSmithKline Pharmaceuticals were trading at Rs 1,430.35 per scrip on BSE, up 0.38 per cent over previous close.
Click one of our representatives below to chat on WhatsApp ,no call facility whatsaap this numbers only Chat .
email us for any inquiry email@example.com
hello Interested in your products!!
Upload Pdf Or Excel File